tiprankstipranks
Trending News
More News >
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
:2TZ
2TZ
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
RESEARCH TOOLSreports

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Revenue

Compare
0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had a revenue of 1.65B in the quarter ending Sep 30, 2024, with -12.40%. This bring the company's revenue in the last twelve months to 8.04B, Increased -0.72%. In the fiscal year ending Dec 31, 2023, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had annual revenue of 8.22B with -0.33% growth.
Revenue (ttm)
8.04B
Revenue Growth
P/S Ratio
0.30
Revenue/Employee
€1,673,583
Employees
4,913
Market Cap
€2.43B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20238.22B-26.94M-0.33%
Dec 31, 20228.25B1.34B+19.42%
Dec 31, 20216.91B303.89M+4.60%
Dec 31, 20206.60B-390.23M-5.58%
Dec 31, 20196.99B635.26M+9.99%
Dec 31, 20186.36B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis